Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NOVADAQ TECHNOLOGIES INC. T.NDQ

"Novadaq Technologies Inc develops & commercializes medical imaging & therapeutic devices for use in the operating room. Its proprietary imaging platform can be used to visualize blood vessels, nerves & the lymphatic system during surgical procedures."


TSX:NDQ - Post by User

Post by factsfinderon Mar 30, 2014 8:31pm
323 Views
Post# 22388219

Going Ons

Going Ons
why the Ceo continues to dump his shares, could he be RIGHT ?"

 
"The company's interest coverage has been lower than its Industry
Group average for each of the past five years.
-
n inventory of 101.3 is
 
DETAILED STOCK REPORT
Report Date: March 28, 20
"NDQ currently has an Earnings Rating of 2, with two of three
components rated as a bearish 4 or less: Earnings Surprise (2) and
Broker Recommendation (4). The average Earnings Rating for its
Advanced Medical Equipment Industry is 4.0 and the S&P/TSX
COMPOSITE average is 5.4.
-
Over the past 4 quarters, the company has reported 0 positive (>2%),
3 negative (<-2%), and 1 in-line (within 2%) surprises. The average
surprise for this time period has been -37.5%. Most recently on
02/06/14, the company reported quarterly earnings of -0.06 per share,
a negative surprise of -93.6% below the consensus of -0.03.
-
NDQ's current quarter consensus estimate has decreased notably over
the past 90 days from -0.02 to -0.05, a loss of -104.5%. This trails the
average Advanced Medical Equipment Industry move of -52.0% during
the same time period..."

NEGATIVE OUTLOOK:
Multiples significantly
above the market or the stock's historic norms... "
<< Previous
Bullboard Posts
Next >>